Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Feb 20;2(4):634–644. doi: 10.1016/j.ekir.2017.01.016

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 International Society of Nephrology. Published by Elsevier Inc.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Percent changes in serum intact parathyroid hormone (iPTH) and albumin-corrected calcium (cCa) during the study period (multiple-dose i.v. injections and follow-up). Etelcalcetide was injected via the venous blood line after dialysis on days 1, 3, 6, 8, 10, 13, 15, 17, 20, 22, 24, and 27 in hemodialysis patients with secondary hyperparathyroidism (SHPT). Blood samples were obtained before each dialysis. Data are expressed as mean ± SD. (a) iPTH levels following drug administration (from day 1 to day 3, and from day 27 to day 29). (b) cCa levels following drug administration (from day 1 to day 3, and from day 27 to day 29).